In conclusion, our findings suggest that in the setting of MI, a dysbalance towards pathological pathways occurs and leads to a deterioration of cardiac remodelling and function, which can be corrected by lithium administration through an Akt/mTOR pathway. The gene discussed is AKT1; the disease is myocardial infarction.